These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 19498252)

  • 1. [Optimal scan timing for Gd-EOB-DTPA enhanced liver dynamic MR imaging].
    Akimoto S; Mori H; Fujii T; Furuya K
    Nihon Hoshasen Gijutsu Gakkai Zasshi; 2009 May; 65(5):626-30. PubMed ID: 19498252
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatic hemangiomas: difference in enhancement pattern on 3T MR imaging with gadobenate dimeglumine versus gadoxetate disodium.
    Gupta RT; Marin D; Boll DT; Husarik DB; Davis DE; Feuerlein S; Merkle EM
    Eur J Radiol; 2012 Oct; 81(10):2457-62. PubMed ID: 22138122
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Contrast agent Gd-EOB-DTPA (EOB·Primovist®) for low-field magnetic resonance imaging of canine focal liver lesions.
    Yonetomi D; Kadosawa T; Miyoshi K; Nakao Y; Homma E; Hanazono K; Yamada E; Nakamura K; Ijiri A; Minegishi N; Maetani S; Hirayama K; Taniyama H; Nakade T
    Vet Radiol Ultrasound; 2012; 53(4):371-80. PubMed ID: 22548505
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Contrast-enhanced magnetic resonance cholangiography with Gd-BOPTA and Gd-EOB-DTPA in healthy subjects.
    Dahlström N; Persson A; Albiin N; Smedby O; Brismar TB
    Acta Radiol; 2007 May; 48(4):362-8. PubMed ID: 17453513
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dynamic contrast-enhanced magnetic resonance imaging of abdominal solid organ and major vessel: comparison of enhancement effect between Gd-EOB-DTPA and Gd-DTPA.
    Tamada T; Ito K; Sone T; Yamamoto A; Yoshida K; Kakuba K; Tanimoto D; Higashi H; Yamashita T
    J Magn Reson Imaging; 2009 Mar; 29(3):636-40. PubMed ID: 19243060
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of hepatobiliary uptake of Gd-EOB-DTPA on the hepatic venous phase of dynamic magnetic resonance imaging on a 3.0-T apparatus: comparison between Gd-EOB-DTPA and Gd-DTPA.
    Fujinaga Y; Ohya A; Matsushita T; Kurozumi M; Ueda K; Kitou Y; Ueda H; Kadoya M
    Jpn J Radiol; 2011 Dec; 29(10):695-700. PubMed ID: 22009420
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection and characterization of focal liver lesions: a Japanese phase III, multicenter comparison between gadoxetic acid disodium-enhanced magnetic resonance imaging and contrast-enhanced computed tomography predominantly in patients with hepatocellular carcinoma and chronic liver disease.
    Ichikawa T; Saito K; Yoshioka N; Tanimoto A; Gokan T; Takehara Y; Kamura T; Gabata T; Murakami T; Ito K; Hirohashi S; Nishie A; Saito Y; Onaya H; Kuwatsuru R; Morimoto A; Ueda K; Kurauchi M; Breuer J
    Invest Radiol; 2010 Mar; 45(3):133-41. PubMed ID: 20098330
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dynamic contrast-enhanced MRI of the liver in Mrp2-deficient rats using the hepatobiliary contrast agent Gd-EOB-DTPA.
    Saito S; Obata A; Kashiwagi Y; Abe K; Murase K
    Invest Radiol; 2013 Jul; 48(7):548-53. PubMed ID: 23442774
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Liver tumors: comparison of MR imaging with Gd-EOB-DTPA and Gd-DTPA.
    Vogl TJ; Kümmel S; Hammerstingl R; Schellenbeck M; Schumacher G; Balzer T; Schwarz W; Müller PK; Bechstein WO; Mack MG; Söllner O; Felix R
    Radiology; 1996 Jul; 200(1):59-67. PubMed ID: 8657946
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of the Magnetic Field Strength on Image Contrast in Gd-EOB-DTPA-enhanced MR Imaging: Comparison between 1.5T and 3.0T.
    Hata H; Inoue Y; Nakajima A; Komi S; Miyatake H
    Magn Reson Med Sci; 2017 Apr; 16(2):109-114. PubMed ID: 27151747
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gd-EOB-DTPA enhanced MRI of the liver: correlation of relative hepatic enhancement, relative renal enhancement, and liver to kidneys enhancement ratio with serum hepatic enzyme levels and eGFR.
    Talakic E; Steiner J; Kalmar P; Lutfi A; Quehenberger F; Reiter U; Fuchsjäger M; Schöllnast H
    Eur J Radiol; 2014 Apr; 83(4):607-11. PubMed ID: 24380639
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MR imaging in patients with suspected liver metastases: value of liver-specific contrast agent Gd-EOB-DTPA.
    Zech CJ; Herrmann KA; Reiser MF; Schoenberg SO
    Magn Reson Med Sci; 2007; 6(1):43-52. PubMed ID: 17510541
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MR liver imaging with Gd-EOB-DTPA: The need for different delay times of the hepatobiliary phase in patients with different liver function.
    Liang M; Zhao J; Xie B; Li C; Yin X; Cheng L; Wang J; Zhang L
    Eur J Radiol; 2016 Mar; 85(3):546-52. PubMed ID: 26860666
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dilution method of gadolinium ethoxybenzyl diethylenetriaminepentaacetic acid (Gd-EOB-DTPA)-enhanced magnetic resonance imaging (MRI).
    Motosugi U; Ichikawa T; Sou H; Sano K; Ichikawa S; Tominaga L; Araki T
    J Magn Reson Imaging; 2009 Oct; 30(4):849-54. PubMed ID: 19787734
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Spiral flow-generating tube for saline chaser improves aortic enhancement in Gd-EOB-DTPA-enhanced hepatic MRI.
    Iyama A; Nakaura T; Iyama Y; Kidoh M; Nagayama Y; Oda S; Utsunomiya D; Namimoto T; Morita K; Yuba K; Yamashita Y
    Eur Radiol; 2019 Apr; 29(4):2009-2016. PubMed ID: 30255255
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of Gd-EOB-DTPA and Gd-DTPA for contrast-enhanced MR imaging of liver tumors.
    Clemént O; Mühler A; Vexler VS; Kuwatsuru R; Berthezène Y; Rosenau W; Brasch RC
    J Magn Reson Imaging; 1993; 3(1):71-7. PubMed ID: 8428104
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gd-EOB-DTPA-enhanced MR imaging: evaluation of hepatic enhancement effects in normal and cirrhotic livers.
    Tamada T; Ito K; Higaki A; Yoshida K; Kanki A; Sato T; Higashi H; Sone T
    Eur J Radiol; 2011 Dec; 80(3):e311-6. PubMed ID: 21315529
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Optimization of the dynamic, Gd-EOB-DTPA-enhanced MRI of the liver: the effect of the injection rate.
    Schmid-Tannwald C; Herrmann K; Oto A; Panteleon A; Reiser M; Zech C
    Acta Radiol; 2012 Nov; 53(9):961-5. PubMed ID: 23024179
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vascular and hepatic enhancements at MR imaging: comparison of Gd-EOB-DTPA and Gd-DTPA in the same subjects.
    Lin YH; Hwang RM; Chen BB; Hsu CY; Yu CW; Kao JH; Lee HS; Liang PC; Wei SY; Shih TT
    Clin Imaging; 2014; 38(3):287-91. PubMed ID: 24556332
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TWIST-VIBE five-arterial-phase technology decreases transient severe motion after bolus injection of Gd-EOB-DTPA.
    Li H; Xiao Y; Wang S; Li Y; Zhong X; Situ W; Xiao E; Zhang Z
    Clin Radiol; 2017 Sep; 72(9):800.e1-800.e6. PubMed ID: 28476245
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.